Fever and Hypotension Vs. Frank Septic Shock: Elderly Patients Taking Vasodilators Who Present with Fever and Hypotension Have a Higher Incidence of Negative Blood Cultures. A Retrospective Analysis of 3,726 Patients.

Author:

Dumanis Guy1,Vaisman Adva2,Issawy Mariana3,Gilboa Mayan4,Zenilman Chava Landau1,Itelman Edward2,Segal Gad2

Affiliation:

1. Ariel University

2. Chaim Sheba medical center

3. HaEmek Medical Center

4. Sheba Medical Center

Abstract

Abstract

Background. Septic shock is a leading cause of mortality. Yet, blood cultures are negative in many cases, questioning the diagnosis. In the quest for characterization of “culture negative septic shock”, the impact of chronic vasodilating medications was questioned. Methods. This was a retrospective analysis of patients with vital signs compatible with septic shock (fever > 37.9 or < 36ºC and systolic blood pressure < 90 mmHg). Results. The study included 3,726 patients (ages 65 to 90). Of these, 1,382 (37.1%) took chronic vasodilators. This group of patients had a lower rate of positive blood cultures compared to the group that did not receive vasodilators (28.5% vs. 32%; P = 0.026). They were older (median 80 vs. 78 years; P = 0.001), and their background included more cardiovascular diseases (P < 0.001). Their total length of hospital stay was shorter (median 4 vs. 6 days; P < 0.001) yet, they had a higher risk of in-hospital mortality (39% vs. 35.1%; P = 0.019). Taking chronic vasodilators was associated with decreased risk for bacteremia by 16% (P = 0.023). Older age, positive bacterial culture, and chronic vasodilation treatment were independently associated with increased risk for in-hospital mortality by 3% (P < 0.001), 36% (P < 0.001), and 21% (P = 0.009) respectively. Conclusion. Chronic use of vasodilators amongst elderly patients presenting with fever and hypotension is associated with a higher incidence of negative blood cultures. We suggest these patients exhibit a combination of sepsis and shock rather than frank septic shock.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3